We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

99 hedge funds and large institutions have $239M invested in GenMark Diagnostics, Inc in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 24

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

3% more funds holding

Funds holding: 96 → 99 (+3)

58% less capital invested

Capital invested by funds: $571M → $239M (-$332M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
99
Holders Change
+3
Holders Change %
+3.13%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
36
Reduced
24
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$13.4M
2
CC
Casdin Capital
New York
+$7.4M
3
CCM
Cadian Capital Management
New York
+$5.93M
4
Bank of America
Bank of America
North Carolina
+$3.4M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.31M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$21.4M
2
NC
Northpointe Capital
Michigan
-$15M
3
Jennison Associates
Jennison Associates
New York
-$11.1M
4
Millennium Management
Millennium Management
New York
-$5.21M
5
PI
Putnam Investments
Massachusetts
-$4.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
ONB
51
Old National Bancorp
Indiana
$208K +$164K +27,208 +121%
AllianceBernstein
52
AllianceBernstein
Tennessee
$206K – – –
UBS AM
53
UBS AM
Illinois
$206K +$156K +26,000 +111%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$193K -$2.57M -426,867 -90%
Baird Financial Group
55
Baird Financial Group
Wisconsin
$193K – – –
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$185K -$29.4K -4,893 -10%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$181K +$17.3K +2,883 +7%
WI
58
WrapManager Inc
California
$165K +$130K +21,679 +121%
AIG
59
American International Group
New York
$143K +$29.5K +4,902 +17%
CS
60
Credit Suisse
Switzerland
$114K -$185K -30,810 -53%
State Board of Administration of Florida Retirement System
61
State Board of Administration of Florida Retirement System
Florida
$111K – – –
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$94K -$424K -70,504 -76%
Dimensional Fund Advisors
63
Dimensional Fund Advisors
Texas
$92K +$132K +21,960 New
VOYA Investment Management
64
VOYA Investment Management
Georgia
$82K – – –
Teacher Retirement System of Texas
65
Teacher Retirement System of Texas
Texas
$74K +$106K +17,628 New
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$74K +$107K +17,729 New
MWNA
67
Marshall Wace North America
New York
$61K -$2.61M -433,110 -97%
Balyasny Asset Management
68
Balyasny Asset Management
Illinois
$61K +$87.5K +14,540 New
PP
69
Paloma Partners
Connecticut
$58K +$83.2K +13,818 New
PPA
70
Parametric Portfolio Associates
Washington
$56K +$81.3K +13,512 New
RJA
71
Raymond James & Associates
Florida
$55K -$103K -17,100 -56%
Legal & General Group
72
Legal & General Group
United Kingdom
$55K – – –
Squarepoint
73
Squarepoint
New York
$52K +$75.1K +12,480 New
BNP Paribas Financial Markets
74
BNP Paribas Financial Markets
France
$45K +$32.1K +5,333 +98%
SG Americas Securities
75
SG Americas Securities
New York
$43K +$62.6K +10,400 New
1 2
3
4 5

GNMK Hedge Fund Activity: Q4 2017 in Review

99 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2017, worth a combined $239M — down 58% from $571M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new GNMK positions and 15 closed out — a net gain of 3 holders — while 36 added to existing stakes and 24 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $13.4M. The largest seller was Artisan Partners, exiting entirely with an estimated $21.4M sold.

  • 99 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2017, up from 96 in Q3 2017.
  • Funds reported $239M of GenMark Diagnostics, Inc stock for Q4 2017, down 58% quarter-over-quarter.
  • 18 funds opened new GenMark Diagnostics, Inc positions in Q4 2017 and 15 closed out, a net change of +3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2017 was T. Rowe Price Associates, an estimated $13.4M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2017 was Artisan Partners, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2017.